Arié Figer - Researcher Profile | RDL Research Database

Publications

2 shown

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore , David Goldstein , John Hamm +14 more

Purpose Patients with advanced pancreatic cancer have a poor prognosis and there have been no improvements in survival since the introduction of gemcitabine in 1996. Pancreatic ...

2007 Journal of Clinical Oncology 3833 citations

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann , G. Bodoky , Thomas Ruhstaller +17 more

Purpose This phase III trial compared the efficacy and safety of gemcitabine (Gem) plus capecitabine (GemCap) versus single-agent Gem in advanced/metastatic pancreatic cancer. P...

2007 Journal of Clinical Oncology 588 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,421
Institution: Princess Margaret Cancer Centre

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.